Literature DB >> 29649546

Pulmonary immunity and extracellular matrix interactions.

David N O'Dwyer1, Stephen J Gurczynski1, Bethany B Moore2.   

Abstract

The lung harbors a complex immune system composed of both innate and adaptive immune cells. Recognition of infection and injury by receptors on lung innate immune cells is crucial for generation of antigen-specific responses by adaptive immune cells. The extracellular matrix of the lung, comprising the interstitium and basement membrane, plays a key role in the regulation of these immune systems. The matrix consists of several hundred assembled proteins that interact to form a bioactive scaffold. This template, modified by enzymes, acts to facilitate cell function and differentiation and changes dynamically with age and lung disease. Herein, we explore relationships between innate and adaptive immunity and the lung extracellular matrix. We discuss the interactions between extracellular matrix proteins, including glycosaminoglycans, with prominent effects on innate immune signaling effectors such as toll-like receptors. We describe the relationship of extracellular matrix proteins with adaptive immunity and leukocyte migration to sites of injury within the lung. Further study of these interactions will lead to greater knowledge of the role of matrix biology in lung immunity. The development of novel therapies for acute and chronic lung disease is dependent on a comprehensive understanding of these complex matrix-immunity interactions.
Copyright © 2018 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29649546      PMCID: PMC6177325          DOI: 10.1016/j.matbio.2018.04.003

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  127 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 3.  Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

Authors:  Natasha M Rogers; Kedar Ghimire; Maria J Calzada; Jeffrey S Isenberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

4.  Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing.

Authors:  Carolina García-de-Alba; Carina Becerril; Víctor Ruiz; Yolanda González; Silvia Reyes; Jorge García-Alvarez; Moisés Selman; Annie Pardo
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

Review 5.  Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.

Authors:  Christian D Ellson; Rebecca Dunmore; Cory M Hogaboam; Matthew A Sleeman; Lynne A Murray
Journal:  Am J Respir Cell Mol Biol       Date:  2014-08       Impact factor: 6.914

6.  Innate signals from Nod2 block respiratory tolerance and program T(H)2-driven allergic inflammation.

Authors:  Wei Duan; Amit K Mehta; Joao G Magalhaes; Steven F Ziegler; Chen Dong; Dana J Philpott; Michael Croft
Journal:  J Allergy Clin Immunol       Date:  2010-11-04       Impact factor: 10.793

7.  Influence of decorin expression on transforming growth factor-beta-mediated collagen gel retraction and biglycan induction.

Authors:  A Markmann; H Hausser; E Schönherr; H Kresse
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

8.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

Authors:  Nobuo Kanazawa; Ikuo Okafuji; Naotomo Kambe; Ryuta Nishikomori; Mami Nakata-Hizume; Sonoko Nagai; Akihiko Fuji; Takenosuke Yuasa; Akira Manki; Yoshihiko Sakurai; Mitsuru Nakajima; Hiroko Kobayashi; Ikuma Fujiwara; Hiroyuki Tsutsumi; Atsushi Utani; Chikako Nishigori; Toshio Heike; Tatsutoshi Nakahata; Yoshiki Miyachi
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

9.  Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis.

Authors:  Yoshinori Aono; Masami Kishi; Yuki Yokota; Momoyo Azuma; Katsuhiro Kinoshita; Akio Takezaki; Seidai Sato; Hiroshi Kawano; Jun Kishi; Hisatsugu Goto; Hisanori Uehara; Keisuke Izumi; Yasuhiko Nishioka
Journal:  Am J Respir Cell Mol Biol       Date:  2014-12       Impact factor: 6.914

Review 10.  Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology.

Authors:  Jaime M Cyphert; Carol S Trempus; Stavros Garantziotis
Journal:  Int J Cell Biol       Date:  2015-09-10
View more
  9 in total

Review 1.  Immunotherapy: breaching the barriers for cancer treatment.

Authors:  Victor G Martinez; Danielle Park; Sophie E Acton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-01       Impact factor: 6.237

Review 2.  Defining the versican interactome in lung health and disease.

Authors:  Fengying Tang; Jourdan E Brune; Mary Y Chang; Stephen R Reeves; William A Altemeier; Charles W Frevert
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-01       Impact factor: 5.282

3.  TRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway Switching.

Authors:  Rachel G Scheraga; Susamma Abraham; Lisa M Grove; Brian D Southern; James F Crish; Apostolos Perelas; Christine McDonald; Kewal Asosingh; Jeffrey D Hasday; Mitchell A Olman
Journal:  J Immunol       Date:  2020-01-22       Impact factor: 5.422

Review 4.  A pathologic two-way street: how innate immunity impacts lung fibrosis and fibrosis impacts lung immunity.

Authors:  Helen I Warheit-Niemi; Elissa M Hult; Bethany B Moore
Journal:  Clin Transl Immunology       Date:  2019-06-26

Review 5.  Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives.

Authors:  C Randall Harrell; Ruxana Sadikot; Jose Pascual; Crissy Fellabaum; Marina Gazdic Jankovic; Nemanja Jovicic; Valentin Djonov; Nebojsa Arsenijevic; Vladislav Volarevic
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

Review 6.  Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia.

Authors:  David J Morgan; Joshua Casulli; Christine Chew; Emma Connolly; Sylvia Lui; Oliver J Brand; Rizwana Rahman; Christopher Jagger; Tracy Hussell
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

7.  HYAL1 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits HFL-1 Fibroblast Proliferation When Upregulated.

Authors:  Dong Leng; Xiaoxi Huang; Jiawen Yi; Hongying Zhao; Yuhui Zhang
Journal:  Biomed Res Int       Date:  2020-03-11       Impact factor: 3.411

Review 8.  Neutrophils-From Bone Marrow to First-Line Defense of the Innate Immune System.

Authors:  Richard Felix Kraus; Michael Andreas Gruber
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

Review 9.  The Role of Glucocorticoids in Inflammatory Diseases.

Authors:  Sybille D Reichardt; Agathe Amouret; Chiara Muzzi; Sabine Vettorazzi; Jan P Tuckermann; Fred Lühder; Holger M Reichardt
Journal:  Cells       Date:  2021-10-28       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.